Body mass index and treatment response to subcutaneous abatacept in patients with psoriatic arthritis: a post hoc analysis of a phase III trial
Objective This post hoc analysis of the phase III Active PSoriaTic Arthritis RAndomizEd TriAl (ASTRAEA) evaluated the effect of baseline body mass index (BMI) on subsequent response to subcutaneous (SC) abatacept in patients with psoriatic arthritis (PsA).Methods In ASTRAEA, patients with active PsA...
Sparad:
| Huvudupphov: | , , , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
BMJ Publishing Group
2019-06-01
|
| Serie: | RMD Open |
| Länkar: | https://rmdopen.bmj.com/content/5/1/e000934.full |
| Taggar: |
Inga taggar, Lägg till första taggen!
|